跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,360 条关于
“SDH”
全部
1,360
临床试验
824
药物
454
机构
39
资讯
43
3个月前
Rogaratinib Achieves 41.7% Response Rate in SDH-Deficient GIST, Demonstrating Breakthrough Efficacy for Previously Untreatable Tumor Subtype
9个月前
Ascentage Pharma's Olverembatinib Shows 23.1% Response Rate in Rare GIST Subtype with Novel Lipid Metabolism Mechanism
去年
Olverembatinib Receives Third Breakthrough Therapy Designation in China for Ph+ ALL Treatment
去年
Olverembatinib's New Indication for CML-CP Included in China's NRDL
9个月前
Ascentage Pharma Receives FDA and EMA Clearance for Global Phase III Trial of Olverembatinib in Philadelphia Chromosome-Positive ALL
去年
Ascentage Pharma Strengthens Leadership Team with New CFO and Senior VP Appointments
去年
Ascentage Pharma Reports Strong Growth with 93% Increase in Olverembatinib Sales and Historic Lisaftoclax Approval
去年
DiMe's DATAcc Receives FDA Grant to Advance Sensor-Based Digital Health Technologies in Clinical Trials
去年
Dana-Farber Researchers Present Breakthrough Cancer Studies at AACR 2025 Annual Meeting
去年
FDA Approves Vorasidenib as Targeted Therapy for IDH-Mutant Gliomas
第 1 页,共 5 页
上一页
下一页